LOS ANGELES — In the first head-to-head comparison of two blockbuster drugs used in real-world conditions, people who took Mounjaro lost significantly more weight than their counterparts who took Ozempic — and the longer the patients kept taking the drugs, the wider the gap became.
Karen Kaplan is a Staff Writer at the Los Angeles Times. She covers science and medical research, with a focus on topics such as healthcare, climate change, and the impact of the coronavirus pandemic. Her work has been featured in various publications, including Yahoo News and the Boston Herald.